Four liver transplant recipients treated with cyclosporine developed a
reversible neurologic syndrome characterized by a speech disorder lea
ding to mutism. This complication, previously reported in a few liver
transplant recipients treated with the immunosuppressive drug FK506, h
ad not been described with cyclosporine. Recognition of this syndrome
should prompt withdrawal of the drug and avoidance of unnecessary diag
nostic procedures.